We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

Back to rankings

29 hedge funds and large institutions have $5.76M invested in Sophiris Bio, Inc. in 2016 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 6

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

74% more capital invested

Capital invested by funds: $3.31M → $5.76M (+$2.45M)

53% more funds holding

Funds holding: 19 → 29 (+10)

Holders
29
Holders Change
+10
Holders Change %
+52.63%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
9
Reduced
4
Closed
6
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$2.85M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$444K
3
Millennium Management
Millennium Management
New York
+$130K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$121K
5
AL
Airain Ltd
Guernsey
+$119K

Top Sellers

Rank Fund Capital Flow
1
RSCM
Rock Springs Capital Management
Maryland
-$1.05M
2
PAI
Palo Alto Investors
California
-$929K
3
Citadel Advisors
Citadel Advisors
Florida
-$106K
4
Jane Street
Jane Street
New York
-$58K
5
SSA
Schonfeld Strategic Advisors
New York
-$45K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$2.35M +$2.85M +757,033 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.4M +$444K +118,110 +36%
PAI
3
Palo Alto Investors
California
$768K -$929K -247,000 -50%
AL
4
Airain Ltd
Guernsey
$198K +$119K +31,713 +99%
JP Morgan Chase
5
JP Morgan Chase
New York
$139K +$89.5K +23,781 New
VKH
6
Virtu KCG Holdings
New York
$133K +$97.5K +25,907 +152%
Millennium Management
7
Millennium Management
New York
$108K +$130K +34,680 New
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
$100K +$121K +32,143 New
Goldman Sachs
9
Goldman Sachs
New York
$82K +$99.6K +26,481 New
Creative Planning
10
Creative Planning
Kansas
$78K +$91.4K +24,300 +2,700%
AIM
11
Acrospire Investment Management
Illinois
$64K +$22.5K +5,990 +41%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$61K +$3.54K +942 +5%
CAN
13
Cetera Advisor Networks
California
$46K +$56.4K +15,000 New
ARTA
14
A.R.T. Advisors
New York
$41K +$49.7K +13,200 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$34K +$42.1K +11,199 New
BCM
16
Bourgeon Capital Management
Connecticut
$31K +$37.6K +10,000 New
LPL Financial
17
LPL Financial
California
$30K +$37.6K +10,000 New
FMA
18
FNY Managed Accounts
New York
$26.1K +$3.17K +844 +11%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$19K +$361 +96 +2%
UBS Group
20
UBS Group
Switzerland
$12K +$15K +4,000 New
Morgan Stanley
21
Morgan Stanley
New York
$8K +$9.31K +2,475 +1,100%
Wells Fargo
22
Wells Fargo
California
$6K -$7.52K -2,000 -53%
Walleye Trading
23
Walleye Trading
New York
$6K +$6.77K +1,800 New
EWM
24
Edge Wealth Management
New York
$6K +$7.52K +2,000 New
CG
25
Cutler Group
California
$4K +$5.64K +1,500 New
1
2

SPHS Hedge Fund Activity: Q3 2016 in Review

29 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q3 2016, worth a combined $5.76M — up 74% from $3.31M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new SPHS positions and 6 closed out — a net gain of 10 holders — while 9 added to existing stakes and 4 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $2.85M. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $1.05M sold.

  • 29 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q3 2016, up from 19 in Q2 2016.
  • Funds reported $5.76M of Sophiris Bio, Inc. stock for Q3 2016, up 74% quarter-over-quarter.
  • 16 funds opened new Sophiris Bio, Inc. positions in Q3 2016 and 6 closed out, a net change of +10 holders.
  • The largest Sophiris Bio, Inc. buyer in Q3 2016 was Sabby Management, an estimated $2.85M added.
  • The largest Sophiris Bio, Inc. seller in Q3 2016 was Rock Springs Capital Management, an estimated $1.05M sold.

Based on aggregated 13F filings for Q3 2016.